Log in to search using one of your social media accounts:

 

Elekta Introduces Advanced Cancer Treatment to Kingdom of Bhutan

THIMPHU, Bhutan, July 24, 2017 -- (Healthcare Sales &Marketing Network) -- Elekta (EKTA-B.ST) announced today that it has been chosen to deliver the first ever radiation therapy system to the Kingdom of Bhutan. The National Referral Hospital, the largest... Devices, Oncology Elekta, Elekta Compact, linear accelerator, radiotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news

Related Links:

This report demonstrates that although cases of esophageal adenocarcinoma that present as brain metastases typically carry a poor prognosis, with early and aggressive treatment patients can survive well past one year after diagnosis.Case Rep Oncol 2017;10:938 –944
Source: Case Reports in Oncology - Category: Cancer & Oncology Source Type: research
In conclusion, the results of the present study generated an output of the genome alterations in lung adenocarcinoma, and provided a foundation for further investigation of the pathogenesis of lung adenocarcinoma. PMID: 29039585 [PubMed - as supplied by publisher]
Source: Molecular Medicine Reports - Category: Molecular Biology Tags: Mol Med Rep Source Type: research
PET scanning plays key roles in planning the management of patients with lung cancer who are candidates for curative-intent treatment with radiotherapy and has contributed to improvements in survival. 18F-fluorodeoxyglucose –PET is the most important modality for staging, patient selection, and radiotherapy target volume definition in patients with unresectable non–small cell lung cancer. Developments include the availability of alternative tracers, such as 18F-fluorothymidine, for imaging proliferation and a range of hypoxia imaging agents. The role of response-adapted therapy, based on interim PET scans perfo...
Source: PET Clinics - Category: Radiology Authors: Source Type: research
ConclusionIncreased delay to surgery could affect the BCR, as there was a positive association in high-risk group. Further studies with longer follow-up are necessary to assess the impact of wait time on BCR, cancer specific survival and overall survival.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research
BACKGROUNDThere is increasing evidence that radiation therapy (RT) can be omitted for select older patients who are compliant with hormonal blockade, but there is no recent claim‐based analysis for determining patterns of care and guiding possible treatment recommendations. METHODSMedicare beneficiaries who were 65 years old or older and were diagnosed with breast cancer at 1 of 12 cancer centers affiliated with an academic center in the southeastern United States were analyzed. Stage 0 or I patients treated with lumpectomy from 2012 to 2014 were identified. Patient, treatment, and center characteristics were analyzed fo...
Source: Cancer - Category: Cancer & Oncology Authors: Tags: Original Article Source Type: research
We report on a 52-year-old woman with cardiomyopathy following chemotherapy and radiation therapy. The patient did not respond well to b-blockers and angiotensin-converting enzyme inhibitors. After the addition of exogenous phosphocreatine, the patient's cardiac condition improved significantly. PMID: 29038417 [PubMed - in process]
Source: Reviews in Cardiovascular Medicine - Category: Cardiology Tags: Rev Cardiovasc Med Source Type: research
(Northwestern Memorial HealthCare) The Northwestern Medicine Chicago Proton Center will host over 200 leading clinicians, physicists and researchers in the growing field of proton therapy at the 4th Annual Particle Therapy Co-Operative Group North-America (PTCOG-NA) Conference, being held Oct. 23-25, 2017 at the Swiss ô tel Chicago. Conference participants will share the latest clinical, scientific and industrial developments in particle beam therapy, an advanced form of radiation therapy using beams of protons to destroy cancer cells and diseased tissue.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
(ViewRay) A retrospective review of 42 inoperable, locally-advanced pancreatic cancer patients treated at four institutions found that higher delivered radiation doses enabled via ViewRay's MRIdian adaptive MR-guided radiation therapy showed a near doubling of median overall survival (27.8 months compared to 14.8 months) and resulted in favorably lower toxicities (0 percent compared to 15.8 percent grade 3 or higher toxicity).
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
Abstract In radiation treatment planning, the esophagus is an important organ-at-risk that should be spared in patients with head and neck cancer or thoracic cancer who undergo intensity-modulated radiation therapy. However, automatic segmentation of the esophagus from CT scans is extremely challenging because of the structure's inconsistent intensity, low contrast against the surrounding tissues, complex and variable shape and location, and random air bubbles. The goal of this study is to develop an online atlas selection approach to choose a subset of optimal atlases for multi-atlas segmentation to delineate eso...
Source: Physics in Medicine and Biology - Category: Physics Authors: Tags: Phys Med Biol Source Type: research
Conclusions Years after treatment completion, patients who had received chemotherapy and/or radiation exhibited signs of cellular aging, which were in turn associated with elevated inflammatory markers and behavioral symptoms. Prospective studies are needed to determine whether treatment-induced accelerated aging may lead to inflammation and associated behavioral disturbances in cancer survivors.
Source: Brain, Behavior, and Immunity - Category: Neurology Source Type: research
More News: Bhutan Health | Cancer | Cancer & Oncology | Hospitals | Marketing | Pharmaceuticals | Radiation Therapy